4th Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Importation; Non-Interference; and Drug Pricing.

LobbyistCovered position, as disclosed
JONATHAN DORST —
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

Prescription Drug User Fee Act VI reauthorization; 21st Century Cures Proposal.

LobbyistCovered position, as disclosed
JONATHAN DORST —
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Animals ANI

Veterinary Biologics, S.1200 (Fairness to Pet Owners Act).

LobbyistCovered position, as disclosed
JONATHAN DORST —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 1200 (114th)

Accounting ACC

Transparency - Fair Drug Pricing Act - Baldwin/McCain.

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Cost Sharing (Preserving Access to Medicines).

LobbyistCovered position, as disclosed
JONATHAN DORST —
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; 21st Century Cures. CMS Part B Centers for Medicare and Medicaid Innovation Demonstration (CMMI); CMS Rule Blended J Code for Biosimilars.

LobbyistCovered position, as disclosed
JONATHAN DORST —
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.